Evaluation of a pharmacist-provider collaborative clinic for treatment of iron deficiency in patients with heart failure.

Although the median total dose of ferric carboxymaltose was numerically higher in the postimplementation group (1,250 mg vs 750 mg), the postimplementation group’s numerically higher rate of ID therapeutic target attainment (48%, compared to 38% in the preimplementation group) did not reach statistical significance, presumably due to the small sample sizes.

also in 111,027 other papers